CasNo.93106-60-6,Enrofloxacin with high quality and reasonable price,(93106-60-6) Suppliers

0 Metric Ton	Negotiable

Min.Order :0 Metric Ton
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,,Other

Keywords

Enrofloxacin 93106-60-6 Enrofloxacin base

Quick Details

Appearance:White or light yellow crystalline acicular powder
Application:Used as a beast with antibacterial drugs
PackAge:25kg/drum or according to your requirements
ProductionCapacity:|Metric Ton|Day
Storage:Storage: All products should be stored at a dry and ventilated location away from fire and other dangerous goods, and should avoid direct sunlight.
Transportation:by sea or by air

Superiority:

Poultry enrofloxacin

1. Basic information

Enrofloxacin base ,93106-60-6
Enrofloxacin Hcl ,112732-17-9
Quality standard :CPV2010 /USP/EP/BP
Use:Veterinary medicine

Appearance: Light-yellow or light-yellow orange crystalline powder

Purity: 99% min

2.Introduction

Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

3.Specification

Item	Standard	Result
Appearance	Light-yellow or light-yellow orange crystalline powder	Light-yellow crystalline Powder
Melting range	Between 221°C and 226°C	223.0°C~225.5°C
Identification	Meet the requirements	Meet the requirements
Fluoroquinolonic acid	Not more than 0.2%	<0.2%
Ciprofloxacin	Not more than 1.0%	0.15%
Loss on drying	Not more than 3.0%	0.1%
Residue on ignition	Not more than 0.2%	0.04%
Heavy metals	Not more than 20ppm	<20ppm
Assay(on the dried basis)	Not less than 98.5%	99.1%

4.Application

Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Details: